Anxiolytic- and antidepressant-like effects of group III metabotropic glutamate agonist (1S,3R,4S)-1-aminocyclopentane-1,3,4-tricarboxylic acid (ACPT-I) in rats

Polish Journal of Pharmacology

Volumn 54, Issue 6, 2002, Pages 707-710

  Tatarczyńska, Ewa ^a   Pałucha, Agnieszka ^a   Szewczyk, Bernadeta ^a   Chojnacka Wójcik, Ewa ^a   Wierońska, Joanna ^a   Pilc, Andrzej ^a,b  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

(1S,3R,4S) 1 aminocyclopentane 1,3, 4 tricarboxylic acid; Anxiety; Conflict drinking test; Depression; Group III mGlu receptors; Porsolt's test

Indexed keywords

1 AMINOCYCLOPENTANE 1,3,4 TRICARBOXYLIC ACID; ALPHA METHYLSERINE O PHOSPHATE; METABOTROPIC RECEPTOR AGONIST; PHOSPHOSERINE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG SELECTIVITY; FORCED SWIMMING TEST; HIPPOCAMPUS; MALE; NONHUMAN; RAT; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; CYCLOPENTANES; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPOCAMPUS; MALE; RATS; RATS, WISTAR; RECEPTORS, METABOTROPIC GLUTAMATE; TRICARBOXYLIC ACIDS;

EID: 0036971043     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Acher F.C., Tellier F.J., Azerad R., Brabet I.N., Fagni L., Pin J.P.R.: Synthesis and pharmacological characterization of aminocyclopentanetricarboxylic acids: new tools to discriminate between metabotropic glutamate receptor subtypes. J. Med. Chem., 1997, 40, 3119-3129.
2. Cartmell J., Schoepp D.D.: Regulation of neurotransmitter release by metabotropic glutamate receptors. J. Neurochem., 2000, 75, 889-907.
3. Chojnacka-Wójcik E., Kłodzińska A., Pilc A.: Glutamate receptor ligands as anxiolytics. Curr. Opin. Investig. Drugs, 2001, 2, 1112-1119.
4. Chojnacka-Wójcik E., Tatarczyńska E., Pilc A.: The anxiolytic-like effect of metabotropic glutamate receptor antagonists after intrahippocampal injection in rats. Eur. J. Pharmacol., 1997, 319, 153-156.
5. De Colle C., Bessis A.S., Bockaert J., Acher F., Pin J.P.: Pharmacological characterization of the rat metabotropic glutamate receptor type 8a revealed strong similarities and slight differences with the type 4a receptor. Eur. J. Pharmacol., 2000, 394, 17-26.
6. Helton D.R., Tizzano J.P., Monn J.A., Schoepp D.D., Kallman M.J.: Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group II metabotropic glutamate receptors. J. Pharmacol. Exp. Ther., 1998, 284, 651-660.
7. Kłodzińska A., Chojnacka-Wójcik E., Pałucha A., Brański P., Popik P., Pilc A.: Potential anti-anxiety, anti-addictive effects of LY 354740, a selective group II glutamate metabotropic receptors agonist in animal models. Neuropharmacology, 1999, 38, 1831-1839.
8. Pilc A., Kłodzińska A., Nowak G.: A role of glutamate in the treatment of anxiety and depression. Focus on group I metabotropic glutamate (mGlu) receptors. Drugs of the Future, 2002, 27, 1-11.
9. Porsolt R.D., Anton G., Blavet N., Jalfre M.: Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur. J. Pharmacol., 1978, 47, 379-391.
10. Shigemoto R., Kinoshita A., Wada E., Nomura S., Ohishi H., Takada M., Flor P.J., Neki A., Abe T., Nakanishi S., Mizuno N.: Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus. J. Neurosci., 1997, 17, 7503-7522.
11. Spooren W.P.J.M., Vassout A., Neijt H.C., Kuhn R., Gasparini F., Roux S., Porsolt R.D., Gentsch C.: Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenyl-ethynyl)pyridine in rodents. J. Pharmacol. Exp. Ther., 2000, 295, 1267-1275.
12. Tatarczyńska E., Kłodzińska A., Chojnacka-Wójcik E., Pałucha A., Gasparini F., Kuhn R., Pilc A.: Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist. Br. J. Pharmacol., 2001, 132, 1423-1430.
13. Tatarczyńska E., Kłodzinska A., Kroczka B., Chojnacka-Wójcik E., Pilc A.: The antianxiety-like effects of antagonists of group I and agonists; of group II and III metabotropic glutamate receptors after intrahippocampal administration. Psychopharmacology, 2001, 158, 94-99.
14. Vogel J.R., Beer B., Clody D.E.: A simple and reliable conflict procedure for testing anti-anxiety agents. Psychopharmacologia. (Berlin), 1971, 21, 1-7.